Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 7 studies | 22% ± 3% | |
classical monocyte | 5 studies | 30% ± 11% | |
epithelial cell | 5 studies | 27% ± 8% | |
monocyte | 3 studies | 17% ± 2% | |
non-classical monocyte | 3 studies | 31% ± 12% | |
B cell | 3 studies | 24% ± 4% | |
myeloid cell | 3 studies | 34% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5592.66 | 1445 / 1445 | 100% | 170.93 | 183 / 183 |
pancreas | 100% | 5795.01 | 328 / 328 | 100% | 149.28 | 178 / 178 |
lung | 100% | 7259.18 | 578 / 578 | 100% | 159.24 | 1151 / 1155 |
stomach | 100% | 4193.35 | 359 / 359 | 100% | 181.51 | 285 / 286 |
intestine | 100% | 5498.23 | 966 / 966 | 100% | 197.70 | 525 / 527 |
uterus | 100% | 4126.59 | 170 / 170 | 100% | 168.62 | 457 / 459 |
prostate | 100% | 6400.23 | 245 / 245 | 99% | 150.85 | 497 / 502 |
breast | 100% | 5828.03 | 459 / 459 | 99% | 130.83 | 1105 / 1118 |
brain | 99% | 3062.64 | 2610 / 2642 | 100% | 122.53 | 705 / 705 |
skin | 100% | 7523.62 | 1809 / 1809 | 99% | 127.31 | 466 / 472 |
bladder | 100% | 6259.19 | 21 / 21 | 99% | 164.60 | 497 / 504 |
ovary | 100% | 3902.70 | 180 / 180 | 98% | 121.20 | 421 / 430 |
kidney | 100% | 4936.35 | 89 / 89 | 96% | 84.66 | 869 / 901 |
liver | 97% | 4170.01 | 219 / 226 | 96% | 96.87 | 391 / 406 |
adrenal gland | 100% | 7397.52 | 258 / 258 | 87% | 71.37 | 199 / 230 |
thymus | 100% | 3637.87 | 652 / 653 | 76% | 41.21 | 460 / 605 |
adipose | 100% | 6519.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 133.35 | 29 / 29 |
spleen | 100% | 9214.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 166.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 36.39 | 1 / 1 |
muscle | 100% | 7899.85 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4031.27 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6036.90 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 2859.79 | 800 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 54.03 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_0007254 | Biological process | JNK cascade |
GO_0034605 | Biological process | cellular response to heat |
GO_0045087 | Biological process | innate immune response |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0001959 | Biological process | regulation of cytokine-mediated signaling pathway |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0038172 | Biological process | interleukin-33-mediated signaling pathway |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_1904996 | Biological process | positive regulation of leukocyte adhesion to vascular endothelial cell |
GO_0034134 | Biological process | toll-like receptor 2 signaling pathway |
GO_0008063 | Biological process | Toll signaling pathway |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0034162 | Biological process | toll-like receptor 9 signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0010008 | Cellular component | endosome membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IRAK1 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) Alternative protein IRAK1 Interleukin 1 receptor associated kinase 1 |
Synonyms | IRAK |
Description | FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. . |
Accessions | ENST00000444230.5 P51617 H7C2I6 H7C3G8 ENST00000369974.6 [P51617-4] ENST00000455690.5 ENST00000429936.6 ENST00000437278.5 ENST00000443220.1 F8WAB6 ENST00000369973.7 D3YTB5 L8E7M9 H7C224 ENST00000369980.8 [P51617-1] H7C3C1 ENST00000444254.1 H7C1F0 ENST00000393687.6 [P51617-2] |